Bimatoprost and Hydroxyzine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Bimatoprost (bimatoprost) and Hydroxyzine (hydroxyzine hydrochloride). Common drug interactions include death among females.
The phase IV clinical study analyzes what interactions people have when they take Bimatoprost and Hydroxyzine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Bimatoprost?
Bimatoprost has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 2,787 Bimatoprost users. Check the latest studies of Bimatoprost.
What is Hydroxyzine?
Hydroxyzine has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 54,070 Hydroxyzine users. Check the latest studies of Hydroxyzine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
11 people who take Bimatoprost and Hydroxyzine together, and have interactions are studied.

What are the common drug interactions of Bimatoprost and Hydroxyzine, by gender? *:
female:
- Death
- Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
- Diarrhoea
- Dizziness
- Drug hypersensitivity
- Erythema (redness of the skin)
- Groin pain
- Hepatic haemorrhage (bleeding inside liver)
- Hypertension (high blood pressure)
- Migraine (headache)
male:
n/a
What are the common drug interactions of Bimatoprost and Hydroxyzine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
- Retinal dystrophy (progressive weakness and wasting of the retina)
- Vitreous degeneration (serious vision problems in humans)
- Blood pressure fluctuation
- Dizziness
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Vision blurred
60+:
- Death
- Vomiting
- Speech disorder
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Unresponsive to stimuli
- Anaemia (lack of blood)
- Carotid artery occlusion (artery blockage)
- Cerebral haemorrhage (bleeding within the brain)
- Diarrhoea
What are the existing conditions these people have? *
- High Blood Pressure: 3 people, 27.27%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 18.18%
- Milia (dead skin becomes trapped in small pockets at the surface of the skin or mouth): 2 people, 18.18%
- Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 18.18%
- Depression: 2 people, 18.18%
- Growth Of Eyelashes: 2 people, 18.18%
- Itching: 1 person, 9.09%
- Insomnia (sleeplessness): 1 person, 9.09%
- Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
- Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Bimatoprost and Hydroxyzine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Bimatoprost (2,787 reports)
- Hydroxyzine (54,070 reports)
Browse all drug interactions of Bimatoprost and Hydroxyzine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bimatoprost:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Hydroxyzine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bimatoprost and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hydroxyzine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on bimatoprost and hydroxyzine hydrochloride (the active ingredients of Bimatoprost and Hydroxyzine, respectively), and Bimatoprost and Hydroxyzine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Blood Magnesium Decreased and drugs of ingredients of brinzolamide - 10 seconds ago
- Palonosetron and Fatigue Aggravated for Women aged 60+ - 13 seconds ago
- Seroquel and Tylenol drug interactions for women aged 50-59 - 24 seconds ago
- Mitoxantrone and Cervical Spinal Stenosis for Women aged 50-59 - 26 seconds ago
- Drug interactions of Albuterol and Zemplar - 28 seconds ago
- Drug interactions of Escitalopram Oxalate and Fexofenadine Hydrochloride - a minute ago
- Celexa and Zyprexa drug interactions for women aged 40-49 - a minute ago
- Could Klor-Con cause Toothaches? - a minute ago
- Losartan and Hydroxyzine Hydrochloride drug interactions for men aged 60+ - a minute ago
- Could Lactulose cause Anaemia? - a minute ago